Purpose: This study aims to determine the effects of SGLT2 inhibitors on corneal dendritic cell density and corneal nerve measures in type 2 diabetes. Methods: Corneal dendritic cell densities and nerve parameters were measured in people with type 2 diabetes treated with SGLT2 inhibitors (T2DM-SGLT2i) [n = 23] and those not treated with SGLT2 inhibitors (T2DM-no SGLT2i) [n = 23], along with 24 age and sex-matched healthy controls. Results: There was a reduction in all corneal nerve parameters in type 2 diabetes groups compared to healthy controls (All parameters: p < 0.05). No significant differences in corneal nerve parameters were observed between T2DM-SGLT2i and T2DM-no SGLT2i groups (All parameters: p > 0.05). Central corneal dendritic cells were significantly reduced [mature (p = 0.03), immature (p = 0.06) and total (p = 0.002)] in the T2DM-SGLT2i group compared to the T2DM-no SGLT2i group. Significantly, higher mature (p = 0.04), immature (p = 0.004), total (p = 0.002) dend
A groundbreaking invention by a 14-year-old student in the United States has earned him the title of "America's top young scientist." Heman Bekele, a ninth-grader hailing from Annandale, Virginia, has developed a unique bar of soap with the potential to aid in the treatment of melanoma. This type of skin cancer is diagnosed in approximately 100,000 individuals in the United
Immune cells do not just passively follow chemical cues in order to reach their target. In fact, they are capable of navigating complex environments in a self-organised manner.